CTVA vs ERNA · P/E 42, rev $16.91B vs P/E 0.0, rev $582.0K
Corteva Inc (CTVA) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
CTVA currently screens at market cap $51.52B and trailing P/E 41.6. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the CTVA and ERNA stock pages for the full models.
Not investment advice.